SHMT2 promotes thyroid cancer metastasis through epigenetic activation of AKT signaling
Xuetian Yue(Shandong University), Jinghui Lu(Shandong University)
Cited by 0
Related Papers
Gain-of-function mutant p53 activates small GTPase Rac1 through SUMOylation to promote tumor progression
|Genes & Development|2017|48
<scp>SREBF2–STARD4</scp> axis confers sorafenib resistance in hepatocellular carcinoma by regulating mitochondrial cholesterol homeostasis
|Cancer Science|2022|36
SHMT2 promotes papillary thyroid cancer metastasis through epigenetic activation of AKT signaling
|Cell Death and Disease|2024|22
ZHX2 inhibits thyroid cancer metastasis through transcriptional inhibition of S100A14
|Cancer Cell International|2022|21
P4HA2 promotes the progression of papillary thyroid cancer by enhancing degradation of IκBα to activate NF-κB signaling pathway
|Cancer Cell International|2025|1